Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_assertion description "[In the current study, we found that overexpression of OLIG2 was not only found in oligodendroglioma samples and normal neural tissue but also in a wide spectrum of malignant cell lines including leukemia, non-small cell lung carcinoma, melanoma, and breast cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_assertion evidence source_evidence_literature NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_assertion SIO_000772 16103065 NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_assertion wasDerivedFrom befree-2016 NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_assertion wasGeneratedBy ECO_0000203 NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.
- befree-2016 importedOn "2016-02-19" NP508987.RA2T9SM_I0w_mRzw1mD793Asc1UjcTsCba32O9Sj_By3w130_provenance.